SCHEMBL223944

SCHEMBL223944

c1cc(-c2ccc(-c3cccc4c3[nH]c3ccccc34)cc2)nc(-c2ccc(-c3cccc4c3[nH]c3ccccc34)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.49
KIF11 P52732 4/20 0.46
PARP14 Q460N5 5/20 0.43
HTR2B P41595 2/20 0.43
HTR5A P47898 2/20 0.43
TDO2 P48775 3/20 0.43
CDK4 P11802 4/20 0.43
CCND1 P24385 4/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
RAB9A P51151 1/20 0.42
IDO1 P14902 1/20 0.42
CCNB2 O95067 1/20 0.42
CCNE2 O96020 1/20 0.42
CDK1 P06493 1/20 0.42
CCNB1 P14635 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
CCNB3 Q8WWL7 1/20 0.42
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25822165 0.88 BCHE (0.55) BCHEKIF11PARP14HTR2BHTR5A
SCHEMBL29407801 0.88 KIF11 (0.57) BCHEKIF11PARP14HTR2BHTR5A
SCHEMBL208888 0.88 KIF11 (0.57) BCHEKIF11PARP14HTR2BHTR5A
SCHEMBL38828 0.88 KIF11 (0.57) BCHEKIF11PARP14HTR2BHTR5A
SCHEMBL1326376 0.88 KIF11 (0.57) BCHEKIF11PARP14HTR2BHTR5A
SCHEMBL30641449 0.88 KIF11 (0.57) BCHEKIF11PARP14HTR2BHTR5A
SCHEMBL15948245 0.88 BCHE (0.47) BCHEKIF11PARP14HTR2BHTR5A
SCHEMBL1326378 0.86 KIF11 (0.55) BCHEKIF11PARP14HTR2BHTR5A
SCHEMBL30985273 0.84 CDK4 (0.54) BCHEKIF11PARP14HTR2BHTR5A
SCHEMBL17969001 0.84 CDK4 (0.54) BCHEKIF11PARP14HTR2BHTR5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2416627-B1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2019-01-02 EP disclosed
US-9299947-B2 Organic electroluminescent device having an electron- and /or exciton-blocking layer comprising an indolocarbazole compound NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2016-03-29 US disclosed
US-8962158-B2 Material having indolocarbazole compound for phosphorescent light-emitting element and organic electroluminescent element using the same NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2015-02-24 US disclosed
EP-2416397-B1 MATERIAL FOR PHOSPHORESCENT LIGHT-EMITTING ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME NIPPON STEEL & SUMIKIN CHEM CO (JP) 2014-08-20 EP disclosed
EP-2416397-A1 MATERIAL FOR PHOSPHORESCENT LIGHT-EMITTING ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME Nippon Steel Chemical Co., Ltd. (JP) 2012-02-08 EP disclosed
EP-2416627-A1 ORGANIC ELECTROLUMINESCENT DEVICE Nippon Steel Chemical Co., Ltd. (JP) 2012-02-08 EP disclosed
US-20120007070-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2012-01-12 US disclosed
US-20120001165-A1 MATERIAL FOR PHOSPHORESCENT LIGHT-EMITTING ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120001165-A1 MATERIAL FOR PHOSPHORESCENT LIGHT-EMITTING ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME LEF1, ELOC, ELP1 BCHE 4590/4885KIF11 3048/4885PARP14 3063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.